Prediction of drug response and adverse drug reactions: From twin studies to Next Generation Sequencing-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prediction of drug response and adverse drug reactions: From twin studies to Next Generation Sequencing

Published:2019-03 Issue: Volume:130 Page:65-77
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Lauschke Volker M.,Ingelman-Sundberg Magnus^ORCID

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference132 articles.

1. Analysis of population-specific pharmacogenomic variants using next-generation sequencing data;Ahn;Sci. Rep.,2017

2. Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy;Alexanderson;Br. Med. J.,1969

3. Long read nanopore sequencing for detection of HLA and CYP2D6 variants and haplotypes;Ammar;F1000Research,2015

4. A randomized and clinical effectiveness trial comparing two pharmacogenetic algorithms and standard care for individualizing warfarin dosing (CoumaGen-II);Anderson;Circulation,2012

5. An atlas of active enhancers across human cell types and tissues;Andersson;Nature,2014

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MALDI-TOF MS-based SNP assay used to determine the appropriate antidepression for Chinese patients;Journal of Pharmaceutical and Biomedical Analysis;2025-01

2. Long-read sequencing of CYP2D6 may improve psychotropic prescribing and treatment outcomes: A systematic review and meta-analysis;Journal of Psychopharmacology;2024-09-11

3. Targeted next-generation sequencing panel to investigate antiplatelet adverse reactions in acute coronary syndrome patients undergoing percutaneous coronary intervention with stenting;Thrombosis Research;2024-08

4. Aspiring to equity: race vs ethnicity in clinical research;Blood Advances;2024-07-23

5. Enzalutamide: Understanding and Managing Drug Interactions to Improve Patient Safety and Drug Efficacy;Drug Safety;2024-04-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3